Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04224688 |
|---|---|
| Brief Title: | A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) (myOpportunITy2) |
| First Submitted : | January 8, 2020 |
| First Submitted that Met QC Criteria : | January 8, 2020 |
| First Posted : | January 13, 2020 |
| Last Update Submitted that Met QC Criteria : | January 14, 2021 |
| Last Update Posted : | January 15, 2021 (Estimate) |